LAVA Medtech Acquisition ...

NASDAQ: LVAC · Real-Time Price · USD
10.43
0.00 (0.00%)
At close: May 10, 2023, 9:30 PM

LAVA Medtech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a
Operating Income
-869.68K -188.07K 188.78K -157.54K 297.46K -6.15K -1K
Interest Income
1.7M 694.45K 159.17K n/a n/a n/a n/a
Pretax Income
4.81M 21.41M 20.84M 19.06M 17.95M -6.15K -1K
Net Income
4.5M 21.31M 20.84M 19.09M 17.97M -6.15K -1K
Selling & General & Admin
1.3M 1.23M 903.91K 604.41K 204.24K 6.15K 1K
Research & Development
n/a n/a n/a n/a n/a n/a n/a
Other Expenses
262.59K 155.18K 100K 55.18K n/a n/a n/a
Operating Expenses
1.56M 1.38M 1M 659.59K 204.24K 6.15K 1K
Interest Expense
n/a -17.66M -17.66M -17.66M -17.66M n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.56M 1.38M 1M 659.59K 204.24K 6.15K 1K
Income Tax Expense
304.29K 96.67K -4.36K -28.24K -19.15K n/a n/a
Shares Outstanding (Basic)
14.38M 14.38M 14.38M 14.38M 14.38M 14.37M 14.37M
Shares Outstanding (Diluted)
14.38M 14.38M 14.38M 14.38M 14.38M 14.37M 14.37M
EPS (Basic)
0.51 1.48 1.45 1.33 1.25 -0.00 -0.00
EPS (Diluted)
0.51 1.48 1.45 1.33 1.25 -0.00 -0.00
EBITDA
-5.82M 13.25M 13.62M 15.93M 17.95M -6.15K -1K
EBIT
-487.68K 193.93K 193.93K -151.39K 303.61K n/a n/a
Depreciation & Amortization
-5.36M 13.03M 13.49M 16.2M 17.76M 109.81K 55.81K